What is Gleevec?

Gleevec (imatinib) is a targeted therapy medication used to treat certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It is taken orally in the form of a tablet, usually once or twice a day. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as other individual factors. Gleevec has been a significant breakthrough in cancer treatment and has significantly improved the prognosis and quality of life for patients with CML and GISTs.

Posted

in

by

pillarhealth

Tags:

Comments

Leave a Reply

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL NOR FINANCIAL ADVICE.

Pillar Health Pte. Ltd. (UEN 202310045D) does not provide any financial nor medical advice.

The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

No material on this site is intended to be a substitute for professional financial advice. Always seek the advice of your financial advisor with any questions you may have regarding any financial related questions, and never disregard professional financial advice because of something you have read on this website.

You have reviewed and hereby agree to the Terms of Use for accessing this Website.

You hereby consent to the collection, use and disclosure of our Personal Data below by Pillar Health Pte Ltd on the terms and conditions set out in the Personal Data Protection Policy.

I agree I do not agree

RSS
Follow by Email
Facebook
Instagram